Presentation TCT 2018

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

Presenter: Hendrik Treede

September 21, 2018

REGISTER for free or LOG IN to view this content

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

Structural Heart

Presentation

TCT 2018

Aortic Valve

Up Next

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: Andrejs Erglis

September 21, 2018

More slides +

Presentation TCT 2018

TCT-44: Comparative Effectiveness and Safety of Five Leading New-Generation TAVI Devices: 12-Month Results from The RISPEVA Study

Presenter: Giuseppe Biondi-Zoccai

September 21, 2018

Presentation TCT 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Dean J. Kereiakes

September 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.